icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
 
 
 
Global Burden of Cervical Cancer in HIV-Positive
Women on Antiretroviral Therapy
 
 
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
 
Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV.....
http://www.natap.org/2014/HIV/120814_03.htm
 
EACS/2015: Long lasting viral suppression and immune reconstitution (CD4) of great magnitude reduce the risk of cervical dysplasia in HIV-positive women...
http://www.natap.org/2015/EACS/EACS_59.htm......length of time with higher CD4 & <50 HIV viral load decreased risk a lot
 
Eliane Rohner1, Lukas Bütikofer1, Mhairi Maskew2, Yi-Ming A. Chen3, Ruth Friedman4, GypsyamberD'Souza5, Matthias Egger1, Julia Bohlius1for the International Epidemiologic Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
1University ofBern, Switzerland, 2University ofWitwatersrand, South Africa, 3Kaohsiung Medical University, Taiwan, 4Fundação Oswaldo Cruz (Fiocruz), Brazil, 5Johns Hopkins Bloomberg School ofPublic Health, USA.

croi1a

croi2b